OrganOx £25m raise a ‘step in direction’ of future IPO

Oxford-based medical device company OrganOx raised €29 million to transform organ transplantation practices

OrganOx Raises £25M Growth Funding Round

UK's OrganOx secures £25M funding to prolong preservation of donor's livers for 24 hours before transplant — TFN

OrganOx, a UK-based medical technology company, has raised £25 million in funding, led by Lauxera Capital Partners. The company is known for its innovative liver transplant device that can preserve organs for up to 24 hours. This funding will be used to support research and development, expand their customer base in the US, and prepare for a potential IPO in the future.

OrganOx Secures £25 Million to Advance Liver Transplant Technology

OrganOx is a medical technology company that has developed an automated normothermic machine perfusion device for transporting livers to patients in need of a transplant. Their device can preserve livers for up to 24 hours outside the body, allowing surgeons to evaluate liver function before transplantation and eliminating the need for nighttime surgeries.

A medical technology company that developed a device for transporting livers to patients in need of a transplant.

2 years ago

OrganOx Secures £25 Million to Advance Liver Transplant Technology

ProblemHealthcare

Solution

Covered on